Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation
Murad Atmaca, Sevda Korkmaz, Mehtap Topuz, Osman Mermi
Psychiatry Investig. 2011;8(1):55-57.   Published online 2010 Nov 20     DOI: https://doi.org/10.4306/pi.2011.8.1.55

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

Murad Atmaca
Neuropsychiatric Disease and Treatment.2020; Volume 16: 1043.     CrossRef
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression
Christoforos Iraklis Giakoumatos, David Osser
Harvard Review of Psychiatry.2019; 27(1): 33.     CrossRef
Antidepressants and Sexual Dysfunctions: a Translational Perspective
Jocelien D. A. Olivier, Berend Olivier
Current Sexual Health Reports.2019; 11(3): 156.     CrossRef
The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior
Adriana Alvarez Silva, Alonso Fernández-Guasti
Pharmacology Biochemistry and Behavior.2019; 187: 172817.     CrossRef
Assessment and management of sexual dysfunction in the context of depression
Pratap R. Chokka, Jeffrey R. Hankey
Therapeutic Advances in Psychopharmacology.2018; 8(1): 13.     CrossRef
Antidepressant-Induced Sexual Side Effects: Incidence, Assessment, Clinical Implications, and Management
Dimitry Francois, Ariana Mireille Levin, Eric J. Kutscher, Babatunde Asemota
Psychiatric Annals.2017; 47(3): 154.     CrossRef
A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy
Mariana S. Sousa, Michelle Peate, Sherin Jarvis, Martha Hickey, Michael Friedlander
Therapeutic Advances in Medical Oncology.2017; 9(4): 269.     CrossRef
Affective disorders and sexual function
Bernardo C. Barata
Current Opinion in Psychiatry.2017; 30(6): 396.     CrossRef
Impacts of Pharmacist Intervention on Psychotropic Polypharmacy and Fall Accidents
Yuki Shigetsura, Manami Koike, Yuichiro Kayano, Sachio Fukatsu, Ryoko Ishizuka, Genichi Sugihara, Satoshi Imai, Ikuko Yano, Takayuki Nakagawa, Toshiya Murai, Kazuo Matsubara
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).2016; 42(3): 174.     CrossRef
Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications
Alejandro Szmulewicz, Cecilia Samamé, Pablo Caravotta, Diego J. Martino, Ana Igoa, Diego Hidalgo-Mazzei, Francesc Colom, Sergio A. Strejilevich
International Journal of Bipolar Disorders.2016;[Epub]     CrossRef
Toolbox: Psychotropic medications for augmentation or combination in treatment-resistant depression
Audrey Ng
Mental Health Clinician.2014; 4(5): 212.     CrossRef
Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction
James M Stevenson, Jeffrey R Bishop
Pharmacogenomics.2014; 15(14): 1791.     CrossRef
Antidepressant-related sexual dysfunction — Perspectives from neuroimaging
Heiko Graf, Martin Walter, Coraline D. Metzger, Birgit Abler
Pharmacology Biochemistry and Behavior.2014; 121: 138.     CrossRef
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
Anita H Clayton, Saria El Haddad, Josepha-Pearl Iluonakhamhe, Caridad Ponce Martinez, Alexandra Elizabeth Schuck
Expert Opinion on Drug Safety.2014; 13(10): 1361.     CrossRef
Psychotropic-induced sexual dysfunction
Erik R. Borg, Benjamin Chavez
Mental Health Clinician.2014; 4(3): 138.     CrossRef
Sexual side effects of serotonergic antidepressants: Mediated by inhibition of serotonin on central dopamine release?
Elisabeth Y. Bijlsma, Johnny S.W. Chan, Berend Olivier, Jan G. Veening, Mark J. Millan, Marcel D. Waldinger, Ronald S. Oosting
Pharmacology Biochemistry and Behavior.2014; 121: 88.     CrossRef
Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial
Amirhossein Modabbernia, Hamid Sohrabi, Abbas-Ali Nasehi, Firoozeh Raisi, Sepideh Saroukhani, Amirhossein Jamshidi, Mina Tabrizi, Mandana Ashrafi, Shahin Akhondzadeh
Psychopharmacology.2012; 223(4): 381.     CrossRef